Anastrozole

This page shows anti-doping rule violation data we have registered for Anastrozole.

Number of cases in Anastrozole Last 10 Years

Anastrozole

Anastrozole ranks #35 globally among prohibited substances, with 102 registered cases (0.7% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,670 verified cases. Brazil leads with 20 cases, while Bodybuilding is the most affected sport (37 cases).

Cases of Anastrozole by Sport
Bodybuilding
37
Powerlifting
14
Cycling
8
Weightlifting
8
Track and field
8
Top Sport: Bodybuilding

37

Bodybuilding cases

0%

Of all violations

102

Total Anastrozole cases
Bodybuilding's share of Anastrozole violations 0%
37 of 102

Bodybuilding has the most recorded cases of Anastrozole violations globally, with 37 registered cases — 0% of all 102 verified cases.

Cases of Anastrozole by Country
Brazil
20
USA
10
Russia
8
South Africa
8
Czech Republic
7
Top Country: Brazil

20

Brazil cases

19.6%

Of all violations

102

Total Anastrozole cases
Brazil's share of Anastrozole violations 19.6%
20 of 102

Brazil leads in Anastrozole violations globally, with 20 registered cases — 19.6% of all 102 verified cases.

Global Substance Ranking

Anastrozole ranks #35 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,359
#2 Methandienone
833
#3 Norandrosterone
778
#4 Testosterone
758
···
#35 Anastrozole
102
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 92.2%
94 cases
Female 7.8%
8 cases
Analysis: has a notably higher proportion of male cases (92.2%) compared to the global average (80.2%), a difference of 12 percentage points. Global average: 80.2% male, 19.8% female
Average Suspension Length
42.2
months
Anastrozole
30.1
months
Global average

The average suspension for Anastrozole violations is 42.2 months, longer than the global average of 30.1 months.

This substance was first listed in the WADA Prohibited List in 2004 as an aromatase inhibitor (anti-estrogen).

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,670 verified anti-doping rule violations across all sports and all countries, and is updated regularly.